Calcium cation
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Calcium cation
- DrugBank Accession Number
- DB14577
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 40.078
Monoisotopic: 39.962591155 - Chemical Formula
- Ca
- Synonyms
- Calcium (2+)
- Calcium ions
- calcium(2+) ion
- Calcium(2+)ions
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbciximab The therapeutic efficacy of Calcium cation can be decreased when used in combination with Abciximab. Acebutolol The therapeutic efficacy of Acebutolol can be decreased when used in combination with Calcium cation. Acenocoumarol The therapeutic efficacy of Calcium cation can be decreased when used in combination with Acenocoumarol. Acetyldigitoxin Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin. Alendronic acid The serum concentration of Alendronic acid can be decreased when it is combined with Calcium cation. - Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image POLİFLEKS LAKTATLI RİNGER IV İNFÜZYON İÇİN ÇÖZELTİ, 100 ML (PVC TORBA) SETLI Calcium cation (4 mEq/L) + Chloride ion (112 mEq/L) + Lactic acid (26.77 mEq/L) + Potassium cation (5.37 mEq/L) + Sodium cation (129.3 mEq/L) Solution Intravenous POLİFARMA İLAÇ SAN. VE TİC. A.Ş. 2005-02-21 Not applicable Turkey POLİFLEKS LAKTATLI RİNGER IV İNFÜZYON İÇİN ÇÖZELTİ, 100 ML (PVC TORBA) SETSİZ Calcium cation (4 mEq/L) + Chloride ion (112 mEq/L) + Lactic acid (26.77 mEq/L) + Potassium cation (5.37 mEq/L) + Sodium cation (129.3 mEq/L) Solution Intravenous POLİFARMA İLAÇ SAN. VE TİC. A.Ş. 2005-02-21 Not applicable Turkey POLİFLEKS LAKTATLI RİNGER IV İNFÜZYON İÇİN ÇÖZELTİ, 1000 CC SETLI Calcium cation (4 mEq/L) + Chloride ion (112 mEq/L) + Lactic acid (26.77 mEq/L) + Potassium cation (5.37 mEq/L) + Sodium cation (129.3 mEq/L) Solution Intravenous POLİFARMA İLAÇ SAN. VE TİC. A.Ş. 2005-02-21 Not applicable Turkey POLİFLEKS LAKTATLI RİNGER IV İNFÜZYON İÇİN ÇÖZELTİ, 1000 CC SETSİZ Calcium cation (4 mEq/L) + Chloride ion (112 mEq/L) + Lactic acid (26.77 mEq/L) + Potassium cation (5.37 mEq/L) + Sodium cation (129.3 mEq/L) Solution Intravenous POLİFARMA İLAÇ SAN. VE TİC. A.Ş. 2005-02-21 Not applicable Turkey POLİFLEKS LAKTATLI RİNGER IV İNFÜZYON İÇİN ÇÖZELTİ, 150 ML (PVC TORBA) SETLI Calcium cation (4 mEq/L) + Chloride ion (112 mEq/L) + Lactic acid (26.77 mEq/L) + Potassium cation (5.37 mEq/L) + Sodium cation (129.3 mEq/L) Solution Intravenous POLİFARMA İLAÇ SAN. VE TİC. A.Ş. 2005-02-21 Not applicable Turkey
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2M83C4R6ZB
- CAS number
- 14127-61-8
- InChI Key
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N
- InChI
- InChI=1S/Ca/q+2
- IUPAC Name
- calcium(2+) ion
- SMILES
- [Ca++]
References
- General References
- TITCK: Polifleks Laktatli Ringer (Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride) Intravenous Infusion [Link]
- External Links
- Human Metabolome Database
- HMDB0000464
- ChemSpider
- 266
- 1316581
- ChEBI
- 29108
- PharmGKB
- PA164712582
- PDBe Ligand
- DY
- PDB Entries
- 158d / 196d / 1a0j / 1a0s / 1a0t / 1a14 / 1a25 / 1a29 / 1a2q / 1a2t … show 14103 more
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Intravenous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -0.57 Chemaxon pKa (Strongest Acidic) 3.09 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 0 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 107.998886 predictedDeepCCS 1.0 (2019) [M+H]+ 109.7226 predictedDeepCCS 1.0 (2019) [M+Na]+ 116.53325 predictedDeepCCS 1.0 (2019)
Drug created at July 20, 2018 21:49 / Updated at May 29, 2021 18:15